| Period Ending | Mar 30, 2012 | Mar 30, 2011 | Mar 30, 2010 |
|---|
|
Total Revenue
|
3,240
|
3,162
|
3,246
| | Cost of Revenue | 926 | 1,026 | 1,054 | | |
Gross Profit
|
2,314
|
2,136
|
2,192
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 951 | 878 | 871 |
|
Non Recurring |
-
|
-
|
-
|
|
Others | 1,032 | 1,082 | 1,145 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
331
|
176
|
176
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 0 | 0 | 0 |
|
Earnings Before Interest And Taxes | 331 | 176 | 177 |
|
Interest Expense | 29 | 36 | 33 |
|
Income Before Tax | 302 | 140 | 144 |
|
Income Tax Expense | (28) | (16) | (257) |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 330 | 156 | 401 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
330
|
156
|
401
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
330
|
156
|
401
|
|